Clinical Trial Update: Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating imaging the effects of a serotonin 2A receptor modulator on synaptic density in treatment-resistant depression; currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Treatment Resistant Depression | Phase 2 | Status: RECRUITING